| abstract |
Parenteral formulations for intravenous administration, which are stable for up to 3 years, contain a therapeutically effective amount of 10,11-dihydro-10-hydroxy-carbamazepine, as active ingredient, and glucose and water, said formulations being (a) the active substance is present in the preparation at a concentration of from 2 to 4.5 mg per ml of preparation; (b) the glucose is present in the formulation in an amount of up to 5% by weight based on the total weight of the formulation, and (c) neither an organic co-solvent nor any other dissolution aid is present in the formulation. |